LBL.V -- Stem cell based CoronaVirus treatment; VOLUME!
Güncellendi
LBL.V is hitting highest volume on TSX-V today. Very similar setup to VXL.V from last week, just before it made the big move from .14 to .325 but cheaper and much better financials. Cash flow positive. 8.4M market cap. 93M shares out.
See the most recent news release with regards to positive outcomes in applying their technology to treat the Coronavirus patients in China:
"Recently published results from an investigator-initiated clinical study conducted in China which reported that allogeneic mesenchymal stem cells (MSCs) cured or significantly improved functional outcomes in all seven treated patients with severe COVID-19 pneumonia."
Google "Lattice Biologics to Evaluate Anti-Inflammatory Stem Cell Therapy Treatment of COVID-19 Lung Disease"
See the most recent news release with regards to positive outcomes in applying their technology to treat the Coronavirus patients in China:
"Recently published results from an investigator-initiated clinical study conducted in China which reported that allogeneic mesenchymal stem cells (MSCs) cured or significantly improved functional outcomes in all seven treated patients with severe COVID-19 pneumonia."
Google "Lattice Biologics to Evaluate Anti-Inflammatory Stem Cell Therapy Treatment of COVID-19 Lung Disease"
Not
Well, that worked out ok :)İşlem kapandı: hedefe ulaştı
İlgili yayınlar
Feragatname
Bilgiler ve yayınlar, TradingView tarafından sağlanan veya onaylanan finansal, yatırım, işlem veya diğer türden tavsiye veya tavsiyeler anlamına gelmez ve teşkil etmez. Kullanım Şartları'nda daha fazlasını okuyun.